MYRIAD GENETICS, INC. Finite-Lived Intangible Assets, Accumulated Amortization
MYRIAD GENETICS, INC. (MYGN) had Finite-Lived Intangible Assets, Accumulated Amortization of $374.10 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2026-07-31
- 2026-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $374.10M.
- 2026-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $366.30M.
- 2025-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $358.50M.
- 2025-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $352.80M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization | Finite-Lived Intangible Assets, Accumulated Amortization as first filed |
|---|---|---|
| 2026-06-30 | $374.10M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $366.30M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $358.50M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $352.80M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $347.60M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $338.40M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $328.80M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $318.90M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $308.30M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $306.80M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $296.30M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $284.90M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $274.50M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $263.90M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $253.00M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $241.60M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $232.10M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $222.50M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $212.50M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $202.60M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $282.90M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $269.20M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $254.20M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $238.20M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $222.70M 10-KT · filed 2021-03-16 | |
| 2020-03-31 | $207.30M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $192.10M 10-Q · filed 2020-02-07 | |
| 2019-09-30 | $176.70M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $161.60M 10-KT · filed 2021-03-16 | |
| 2019-03-31 | $146.20M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $131.00M 10-Q · filed 2019-02-06 | |
| 2018-09-30 | $115.80M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $102.30M 10-K · filed 2019-08-13 | |
| 2018-03-31 | $93.00M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $83.60M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $74.30M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $64.90M 10-K · filed 2018-08-24 | $64.80M 10-K · filed 2017-08-09 |
| 2017-03-31 | $55.50M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $46.30M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $37.30M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $31.50M 10-K · filed 2017-08-09 | |
| 2016-03-31 | $28.40M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $25.30M 10-Q · filed 2016-02-03 | |
| 2015-09-30 | $22.20M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $19.00M 10-K · filed 2016-08-10 | |
| 2015-03-31 | $15.86M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $12.72M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $9.59M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $8.30M 10-K · filed 2015-08-12 | $8.24M 10-K · filed 2014-08-13 |
| 2014-03-31 | $5.25M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $4.11M 10-Q · filed 2014-02-05 | |
| 2013-09-30 | $3.86M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $3.62M 10-K · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |